Summary
We investigated the course of thyroid hormones levels in the serum of hyperthyroid patients acutely treated with amiodarone. Ten patients were treated either with amiodarone, 3 × 400 mg daily for 3 days in addition to methimazole, 3 × 20 mg daily for 10 days (Group I;n=5) or with a placebo plus methimazole at the same doses (Group II;n=5). Basal T3, T4 and rT3 serum concentrations were: 297 ng/dl, 16.6 µg/dl and 507 pg/dl, respectively in Group I and 377 ng/dl, 17.6 µg/dl and 362 pg/dl in Group II (NS). Compared with basal values, the drop in serum T3 concentration became significant on Day 1 in Group I, but not until day 5 in Group II. The decrease in serum T3 concentration was significantly higher in Group I than in Group II from Day 1 to Day 7. In Group I, T4 concentration was significantly lower on Days 2, 4 and 6; the percentage drop in T4 calculated from the areas under the curves was higher and the T3/T4 ratio lower on Days 3–5, 7 and 9; rT3 was higher on Days 4 and 5 and its rise was significant on Days 1, 3 and 4. During the follow-up period a transient rise in T4 and T3 concentrations was observed in two patients in Group I when the methimazole dosage was tapered or stopped because of agranulocytosis. In conclusion, in our hyperthyroid patients, amiodarone in conjunction with methimazole induced a greater fall in T3 and T4 than did methimazole alone.
Similar content being viewed by others
References
Abuid J, Larsen PR (1974) Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents. J Clin Invest 54: 201–208
Anastasiou-Nana M, Koutras DA, Levis G (1984) The correlation of serum amiodarone levels with abnormalities in the metabolism of thyroxine. J Endocrinol Invest 7: 405–407
Arteaga E, Lopez JM, Rodriguez JA, Michaud P, Lopez G (1983) Effect of the combination of dexamethasone and sodium iopodate on serum thyroid hormones in Graves' disease. Clin Endocrinol 19: 619–627
Beng CG, Wellby MG, Symons RG, Stuart S, Marshall J (1980) The effects of iopodate on the serum iodothyronine pattern in normal subjects. Acta Endocrinol 93: 175–178
Berger Y, Matteassi JR, Pacco M (1981) Quantitative analysis of amiodarone (L-3428) and one of its metabolite (LB-32812) in plasma by HPLC. Scientific Reports, Sanofi Research Center of Brussels
Binnerts W (1974) Determination of iodine in biological materials. Methods Biochem Anal 22: 251–301
Broekhuyzen J, Larnel R, Sion R (1969) Etudes comparées du transit et du métabolisme de l'amiodarone dans diverses espèces animales et chez l'homme. Arch Int Pharmacodyn Ther 177: 340–359
Burger A, Dinichert D, Nicod P, Jenny M, Lemarchand-Beraud T, Valloton M (1976) Effects of amiodarone on serum T3, rT3, T4 and TSH. A drug influencing peripheral metabolism of thyroid hormones. J Clin Invest 58: 255–259
Burgi H, Wimpfheimer C, Burger A, Zaumbauer W, Rösler H, Lemarchand-Beraud T (1976) Changes of circulating thyroxine, triiodothyronine and reverse triiodothyronine after radiographic contrast agents. J Clin Endocrinol Metab 43: 1203–1209
Fuller PJ, Stockigt JR (1982) Feedback regulation of thyrotropin secretion by thyroid hormones. N Engl J Med 306: 1237
Holt DK, Tucker GT, Jackson PR, Storey CCA (1983) Amiodarone pharmacokinetics. Am Heart J 106: 840–847
Jaggarao N, Sheldon S, Grundy E, Vincent R, Chamberlain D (1982) The effects of amiodarone on thyroid function. Postgrad Med J 58: 693–696
Jonckheer MH, Blockx P, Kaivers R, Wyffels G (1973) Hyperthyroidism as a possible complication of the treatment of ischemic heart disease with amiodarone. Acta Cardiol 28: 192–200
Jonckheer MH, Block P, Broeckaert I, Cornette C, Beckers C (1978) Low T3 syndrome in patients clinically treated with an iodine containing drug amiodarone. Clin Endocrinol 9: 27–35
Kleinmann RE, Vagenakis AG, Braverman LE (1980) The effect of iopanoic acid in the regulation of thyrotropin secretion in euthyroid subjects. J Clin Endocrinol Metab 51: 399–403
Lambert MJ, Burger AG, Galeazzi RL, Engler D (1982) Are selective increases in serum thyroxine (T4) due to iodinated inhibitors of T4 monoiodination indicative of hyperthyroidism? J Clin Endocrinol Metab 55: 1058–1065
Larsen PR (1982a) Thyroid-pituitary interaction. N Engl J Med 306: 23–32
Larsen PR (1982b) Feedback regulation of thyrotropin secretion by thyroid hormones. N Engl J Med 306: 1237
Lindenmeyer M, Sporri S, Staubli M, Studer A, Studer H (1984) Does amiodarone affect heart rate by inhibiting the intracellular generation of triiodothyronine from thyroxine? Br J Pharmacol 82: 275–280
Litvinenko AF, Romashkan NV, Oleinik VA, Lisyanskaya SM, Krivoruk IM (1982) Comparative evaluation of different methods of auricular fibrillation treatment in patients with thyrotoxicosis. Probl Endokrinol (Mosk) 28: 20–24
Massin JP, Thomopoulos P, Karam J, Savoie JC (1971) Le risque thyroidien d'un nouveau coronaro-dilatateur iodé: l'Amiodarone (Cordarone). Ann Endocrinol 32: 438–448
Melmed S, Nademanee K, Reed AW, Hendrickson J, Singh BN, Hershman JM (1981) Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration. J Clin Endocrinol Metab 53: 997–1001
Nademanee K, Singh BN, Phil D, Hendrickson JA, Reed AW, Melmed S, Hershman J (1982) Pharmacokinetic significance of serum rT3 levels during amiodarone treatment: A potential method for monitoring chronic drug therapy. Circulation 66: 202–211
Nagataki S (1974) Effect of excess quantities of iodide. In: Greer MA, Solomon DH (eds) Handbook of physiology, vol 3. Waverly Press, Baltimore p 329
Pritchard D, Singh B, Hurley P (1975) Effects of amiodarone on thyroid function in patients with ischaemic heart disease. Br Heart J 37: 856
Riva E, Arrons L, Latini R, Neyroz P, Urso R (1984) Amiodarone kinetics after single i.v. bolus and multiple dosing in healthy volunteers. Eur J Clin Pharmacol 27: 491–494
Rosenbaum MB, Chiale PA, Halpern MS (1976) Clinical efficacy of amiodarone as an antiarrythmic agent. Am J Cardiol 38: 934–944
Schrub J, Courtois H, Dero M, Vuillermet P (1981) Crise thyrotoxique aiguë: intérêt de l'amiodarone. Sem Hôp Paris 57: 703
Sharp B, Reed A, Tamagna E, Geffner D, Hershman J (1981) Treatment of hyperthyroidism with sodium ipodate in addition to propylthiouracil and propranolol. J Clin Endocrinol Metab 53: 622–625
Sheldon J (1983) Effects of amiodarone in thyrotoxicosis. Br J Med 286: 267–268
Shian LR, Yen CY, Bian TY, Huang HW, Shen DC, Wu SY (1985) A comparative study of the early therapeutic effect of amiodarone and iodine on Graves' thyrotoxicosis. Clin Res 33: 29A (abstract)
Singh BM, Collett JT, Chero CYC (1980) Progress in cardiovascular disease 22: 243–301
Sogol P, Hershman J, Reed A, Dillman W (1983) The effects of amiodarone on serum thyroid hormones and hepatic thyroxine 5′-monodeiodination in rats. Endocrinology 113: 1464–1469
Staubli M, Bircher J, Galeazzi RL, Remund H, Studer H (1983) Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity. Eur J Clin Pharmacol 24: 485–494
Staubli M, Troendle A, Schmid B, Balmer P, Kohler B, Studer H, Bircher J (1985) Pharmacokinetics of amiodarone, desethylamiodarone and other iodine-containing amiodarone metabolites. Eur J Clin Pharmacol 29: 417–423
Wu S, Chopra I, Solomon D, Bennett L (1978a) Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate, an agent for oral cholescystography. J Clin Endocrinol Metab 46: 691–697
Wu S, Chopra I, Solomon D, Johnson D (1978b) The effect of repeated administration of ipodate in hyperthyroidism. J Clin Endocrinol Metab 47: 1358–1362
Zipes DP, Troup PJ (1978) New anti-arrythmic drugs. Am J Cardiol 41: 1005–1024
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Reeth, O., Decoster, C. & Unger, J. Effect of amiodarone on serum T4 and T3 levels in hyperthyroid patients treated with methimazole. Eur J Clin Pharmacol 32, 223–227 (1987). https://doi.org/10.1007/BF00607567
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00607567